DK0950068T3 - Kollagen-bindende proteinsammensatninger og fremgangsmade til anvendelse - Google Patents

Kollagen-bindende proteinsammensatninger og fremgangsmade til anvendelse

Info

Publication number
DK0950068T3
DK0950068T3 DK97926514T DK97926514T DK0950068T3 DK 0950068 T3 DK0950068 T3 DK 0950068T3 DK 97926514 T DK97926514 T DK 97926514T DK 97926514 T DK97926514 T DK 97926514T DK 0950068 T3 DK0950068 T3 DK 0950068T3
Authority
DK
Denmark
Prior art keywords
methods
binding protein
prevention
cna
dna segments
Prior art date
Application number
DK97926514T
Other languages
English (en)
Inventor
Magnus Hook
Joseph M Patti
Karen House-Pompeo
Narayana Sthanam
Jindrich Symersky
Original Assignee
Texas A & M Univ Sys
Uab Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Texas A & M Univ Sys, Uab Research Foundation filed Critical Texas A & M Univ Sys
Application granted granted Critical
Publication of DK0950068T3 publication Critical patent/DK0950068T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1271—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Micrococcaceae (F), e.g. Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/77—Internalization into the cell
DK97926514T 1996-05-16 1997-05-14 Kollagen-bindende proteinsammensatninger og fremgangsmade til anvendelse DK0950068T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1767896P 1996-05-16 1996-05-16

Publications (1)

Publication Number Publication Date
DK0950068T3 true DK0950068T3 (da) 2006-02-13

Family

ID=21783969

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97926514T DK0950068T3 (da) 1996-05-16 1997-05-14 Kollagen-bindende proteinsammensatninger og fremgangsmade til anvendelse

Country Status (9)

Country Link
US (2) US6288214B1 (da)
EP (1) EP0950068B1 (da)
AT (1) ATE309271T1 (da)
AU (1) AU3126097A (da)
CA (1) CA2255669A1 (da)
DE (1) DE69734601T2 (da)
DK (1) DK0950068T3 (da)
ES (1) ES2252785T3 (da)
WO (1) WO1997043314A2 (da)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0950068B1 (en) * 1996-05-16 2005-11-09 THE TEXAS A&M UNIVERSITY SYSTEM Collagen binding protein compositions and methods of use
US6610293B1 (en) * 1997-06-16 2003-08-26 The Henry M. Jackson Foundation For The Advancement Of Military Medicine Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
US6692739B1 (en) * 1998-08-31 2004-02-17 Inhibitex, Inc. Staphylococcal immunotherapeutics via donor selection and donor stimulation
DE69940404D1 (de) * 1998-08-31 2009-03-26 Inhibitex Inc Multikomponenten Impfstoffe gegen Staphylococcus aureus
US6703025B1 (en) * 1998-08-31 2004-03-09 Inhibitex, Inc. Multicomponent vaccines
EP1121149A4 (en) * 1998-08-31 2002-03-20 Inhibitex Inc IMMUNOTHERAPY METHOD FOR STAPHYLOCOCCAL INFECTIONS INCLUDING DONOR SELECTION AND DONOR STIMULATION
US20020092987A1 (en) * 1998-09-05 2002-07-18 Taehee Cho Photo detect device using quantum dots and materialization method thereof
CA2372847A1 (en) 1999-05-10 2000-11-16 Texas A & M Univ Sys COLLAGEN BINDING PROTEINS DERIVED FROM ENTEROCOCKS
US6908994B1 (en) 1999-05-10 2005-06-21 The Texas A&M University System Collagen-binding proteins from enterococcal bacteria
AU4933799A (en) 1999-08-02 2001-02-19 E-Mark Systems Inc. Electronic settlement system, settlement device, and terminal
US20070077256A1 (en) * 1999-11-19 2007-04-05 Los Angeles Biomedical Research Institute Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents
AU2001256958A1 (en) * 2000-03-17 2001-10-03 Inhibitex, Inc. Cross-reactive displacing antibodies from collagen-binding proteins and method of identification and use
GB0014907D0 (en) 2000-06-20 2000-08-09 Univ Sheffield Antigenic polypeptides
MXPA03006651A (es) * 2001-01-26 2004-11-12 Inhibitex Inc Anticuerpos monoclonales para la proteina clfa y metodos para el uso en el tratamiento o prevencion de infecciones.
JP2002253712A (ja) * 2001-03-02 2002-09-10 Endo Mfg Co Ltd ゴルフクラブ
EP1443957A4 (en) * 2001-05-08 2005-10-12 Texas A & M Univ Sys SURFACE PROTEINS FROM GRAM POSITIVE BACTERIA COMPRISING HIGHLY PRESERVED PATTERNS AND ANTIBODIES RECOGNIZING THESE REASONS
US6835378B2 (en) 2001-05-11 2004-12-28 The Texas A&M University System University Method and compositions for inhibiting thrombin-induced coagulation
WO2002102829A2 (en) 2001-06-15 2002-12-27 Inhibitex, Inc. Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus
US7115264B2 (en) * 2001-11-05 2006-10-03 Inhibitex Monoclonal antibodies to the fibronectin binding protein and method of use in treating or preventing infections
US20030153026A1 (en) * 2002-01-04 2003-08-14 Javier Alarcon Entrapped binding protein as biosensors
US6855556B2 (en) * 2002-01-04 2005-02-15 Becton, Dickinson And Company Binding protein as biosensors
CA2475774A1 (en) * 2002-02-21 2003-09-04 Universita' Degli Studi Di Pavia Monoclonal antibodies that are cross-reactive against bacterial collagen binding proteins
JP2005536185A (ja) * 2002-03-05 2005-12-02 インヒビテックス インコーポレーテッド コアグラーゼ陰性ブドウ球菌タンパク質を認識するモノクローナルおよびポリクローナル抗体
CN1787839B (zh) 2003-03-07 2011-09-28 惠氏控股公司 用于抗医院内感染的免疫的多糖-葡萄球菌表面粘附素载体蛋白缀合物
ATE476659T1 (de) * 2004-06-09 2010-08-15 Becton Dickinson Co Sensor für mehrere analyte
ES2472441T3 (es) 2004-09-22 2014-07-01 Glaxosmithkline Biologicals S.A. Composición inmunog�nica para uso en vacunación contra estafilococos
PL1838341T3 (pl) 2005-01-20 2014-04-30 Isconova Ab Kompozycja szczepionki obejmująca białko wiążące fibronektynę lub peptyd wiążący fibronektynę
JP4726109B2 (ja) * 2005-02-10 2011-07-20 昭和電工株式会社 皮膚外用剤、それを用いる皮膚有害微生物の付着予防方法及び増殖防止方法
EP1853306B1 (en) * 2005-02-14 2016-06-15 Epitopix, LLC Polypeptides from staphylococcus aureus and methods of use
US8475798B2 (en) * 2005-06-16 2013-07-02 Inhibitex, Inc. Monoclonal antibodies recognizing a coagulase-negative staphylococcal protein
JP2009502261A (ja) * 2005-07-25 2009-01-29 ナノテクノロジー ビクトリア ピーティーワイ リミテッド マイクロアレイデバイス
WO2007030012A2 (en) * 2005-09-05 2007-03-15 Stichting Voor De Technische Wetenscahappen Extracellular matrix imaging
WO2007100580A2 (en) * 2006-02-22 2007-09-07 The Texas A & M University System Antibodies recognizing a highly expressed putative antigen of ca-mrsa and methods of use
JP2009531387A (ja) 2006-03-30 2009-09-03 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム 免疫原性組成物
AU2007240316A1 (en) 2006-04-20 2007-11-01 Becton, Dickinson And Company Thermostable proteins and methods of making and using thereof
US20180221466A9 (en) * 2006-06-12 2018-08-09 Glaxosmithkline Biologicals S.A. Use of alpha-toxin for treating and preventing staphylococcus infections
WO2009029831A1 (en) * 2007-08-31 2009-03-05 University Of Chicago Methods and compositions related to immunizing against staphylococcal lung diseases and conditions
US9181329B2 (en) 2007-08-31 2015-11-10 The University Of Chicago Methods and compositions related to immunizing against Staphylococcal lung diseases and conditions
WO2010014304A1 (en) * 2008-07-29 2010-02-04 University Of Chicago Compositions and methods related to staphylococcal bacterium proteins
EP2341929B1 (en) 2008-10-06 2017-01-25 University Of Chicago Compositions and methods related to bacterial emp proteins
CA2749367A1 (en) 2009-01-12 2010-07-15 Novartis Ag Cna_b domain antigens in vaccines against gram positive bacteria
NZ614557A (en) 2009-03-23 2015-03-27 Epitopix Llc Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use
JP5747370B2 (ja) * 2009-03-31 2015-07-15 国立大学法人浜松医科大学 高病原性口腔細菌の高感度検出法
HUE057713T2 (hu) 2009-04-03 2022-05-28 Univ Chicago A protein A (SPA) variánsaival kapcsolatos készítmények és módszerek
GB0913680D0 (en) 2009-08-05 2009-09-16 Glaxosmithkline Biolog Sa Immunogenic composition
EP2284193A1 (en) * 2009-08-10 2011-02-16 Kenta Biotech AG Human monoclonal antibody against S. aureus derived apha-toxin and its use in treating or preventing abscess formation
JP5732449B2 (ja) 2010-03-10 2015-06-10 国立大学法人浜松医科大学 高病原性口腔細菌による腸炎誘発原因分子の産生とその高感度検出法
JP2013523818A (ja) 2010-04-05 2013-06-17 ザ・ユニバーシティー・オブ・シカゴ 免疫反応のエンハンサーとしてのプロテインＡ（ＳｐＡ）抗体に関連する組成物および方法
WO2012003474A2 (en) 2010-07-02 2012-01-05 The University Of Chicago Compositions and methods related to protein a (spa) variants
US9095540B2 (en) 2010-09-09 2015-08-04 The University Of Chicago Methods and compositions involving protective staphylococcal antigens
US8182842B1 (en) 2010-11-10 2012-05-22 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Physico-chemical-managed killing of penicillin-resistant static and growing gram-positive and gram-negative vegetative bacteria
WO2012100050A1 (en) * 2011-01-19 2012-07-26 New York Society For The Ruptured And Crippled Maintaining The Hospital For Special Surgery A composition for the attachment of implants to collagen or other components of biological tissue
US8945588B2 (en) 2011-05-06 2015-02-03 The University Of Chicago Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides
GEP201706766B (en) 2011-07-22 2017-10-25 Los Angeles Biomedical Res Center Methods and compositions for vaccinating against staphylococcus aureus
US9556281B2 (en) 2011-08-15 2017-01-31 The University Of Chicago Compositions and methods related to antibodies to staphylococcal protein A
WO2013162746A1 (en) 2012-04-26 2013-10-31 University Of Chicago Staphylococcal coagulase antigens and methods of their use
EP2841101B1 (en) 2012-04-26 2019-08-07 University Of Chicago Compositions and methods related to antibodies that neutralize coagulase activity during staphylococcus aureus disease
US10130691B2 (en) 2013-03-15 2018-11-20 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Compositions and methods for treating fungal and bacterial pathogens
US11531028B2 (en) 2013-05-10 2022-12-20 Nordic Bioscience A/S Collagen type X alpha-1 assay
US10260111B1 (en) 2014-01-20 2019-04-16 Brett Eric Etchebarne Method of detecting sepsis-related microorganisms and detecting antibiotic-resistant sepsis-related microorganisms in a fluid sample
WO2017087838A2 (en) * 2015-11-19 2017-05-26 George Mason University Dual inhibitory action peptidomimetic inhibitor for il-33 and il-1beta
WO2017155949A1 (en) 2016-03-09 2017-09-14 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Methods and kits for use in preventing and treating vulvovaginal candidiasis
PE20211279A1 (es) 2018-10-23 2021-07-19 Dragonfly Therapeutics Inc Proteinas heterodimericas fusionadas con fc
JP2022550884A (ja) 2019-10-02 2022-12-05 ヤンセン ファッシンズ アンド プリベンション ベーフェー スタフィロコッカス（Ｓｔａｐｈｙｌｏｃｏｃｃｕｓ）ペプチドおよび使用方法
EP4138778A1 (en) 2020-04-22 2023-03-01 Dragonfly Therapeutics, Inc. Formulation, dosage regimen, and manufacturing process for heterodimeric fc-fused proteins

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5189015A (en) * 1984-05-30 1993-02-23 Alfa-Laval Agri International Ab Method for prophylactic treatment of the colonization of a Staphylococcus aureus bacterial strain by bacterial cell surface protein with fibronectin and fibrinogen binding ability
GB8516421D0 (en) 1985-06-28 1985-07-31 Biotechnology Interface Ltd Fibronectins
US5300434A (en) * 1987-11-06 1994-04-05 Washington Research Foundation Hybridoma cell line producing an antibody to type-I collagen amino-terminal telopeptide
US5270030A (en) * 1988-12-29 1993-12-14 Bio-Technology General Corp. Fibrin binding domain polypeptide and method of producing
SE9003374D0 (sv) 1990-10-22 1990-10-22 Alfa Laval Agri Int A collagen binding protein as well as its preparation
US5851794A (en) * 1990-10-22 1998-12-22 Alfa Laval Ab Collagen binding protein as well as its preparation
US5980908A (en) * 1991-12-05 1999-11-09 Alfa Laval Ab Bacterial cell surface protein with fibronectin, fibrinogen, collagen and laminin binding ability, process for the manufacture of the protein and prophylactic treatment
US5491130A (en) 1992-11-10 1996-02-13 The United States Of America As Represented By The Department Of Health And Human Services Peptide inhibitors of fibronectin and related collagen-binding proteins
US5624904A (en) * 1993-11-17 1997-04-29 Massachusetts Institute Of Technology Method for treating gram positive septicemia
US6008341A (en) * 1994-08-22 1999-12-28 The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin S. aureus fibrinogen binding protein gene
US5858709A (en) * 1996-10-15 1999-01-12 Smithkline Beecham P.L.C. Fibronectin binding protein B compounds
US6013482A (en) * 1996-10-15 2000-01-11 Smithkline Beecham Plc Cell surface protein compounds
EP0950068B1 (en) * 1996-05-16 2005-11-09 THE TEXAS A&M UNIVERSITY SYSTEM Collagen binding protein compositions and methods of use
US5789171A (en) * 1996-06-20 1998-08-04 Board Of Trustees Of The University Of Arkansas Use of cna, fnba, fnbb, and hlb, gene probes for the strain-specific identification of Staphylococcus aureus

Also Published As

Publication number Publication date
ES2252785T3 (es) 2006-05-16
US6288214B1 (en) 2001-09-11
ATE309271T1 (de) 2005-11-15
DE69734601T2 (de) 2006-08-03
DE69734601D1 (de) 2005-12-15
WO1997043314A3 (en) 1997-12-24
US20020102262A1 (en) 2002-08-01
EP0950068A2 (en) 1999-10-20
WO1997043314A2 (en) 1997-11-20
CA2255669A1 (en) 1997-11-20
EP0950068B1 (en) 2005-11-09
AU3126097A (en) 1997-12-05

Similar Documents

Publication Publication Date Title
DK0950068T3 (da) Kollagen-bindende proteinsammensatninger og fremgangsmade til anvendelse
ATE461709T1 (de) Choline-bindende proteine derivate aus pneumokoken als impfstoff
NZ512574A (en) Novel streptococcus antigens useful as vaccines
NZ524888A (en) Nucleic acids and proteins from streptococcus groups A & B
DE69630457D1 (de) Verbindungen zur immunotherapie und diagnose von tuberkulose
WO1998008542A3 (en) Compounds and methods for treatment and diagnosis of mycobacterial infections
EA200000860A1 (ru) Выделенный полинуклеотид (варианты), полинуклеотид (варианты), вектор (варианты), клетка-хозяин (варианты), выделенный полипептид (варианты), способ его получения (варианты), вакцинная композиция (варианты), способ терапевтического или профилактического лечения стрептококковой бактериальной инфекции у животного (варианты), применение (варианты)
PT750672E (pt) Sequencias de adn para metaloproteases matriciais, sua preparacao e utilizacao.
WO2005007673A3 (en) Immunogenic peptides
WO2002034773A3 (en) Streptococcal genes
DE69841073D1 (de) Fibronektinbindungsprotein abgeleitete peptide, die nicht an fibronektin binden, antikörper dagegen und therapeutische anwendung
WO2001040313A3 (en) Feline immunoregulatory proteins, nucleic acid molecules, and uses thereof
SE9903534D0 (sv) Vaccin
Camussone et al. Immune response and functional role of antibodies raised in heifers against a Staphylococcus aureus CP5 lysate and recombinant antigens vaccine formulated with Iscom Matrix adjuvant
AU7520398A (en) Test kit for tuberculosis diagnosis or the like
ATE515270T1 (de) Phep, eine aminosäurepermease von staphylococcus aureus
WO2004098529A3 (en) Therapeutic compositions and vaccines by glycosyl-phosphatidylinositol (gpi)-anchored cytokines and immunostimulatory molecules
ATE311456T1 (de) Nucleinsäure-moleküle codierend proteine, die die adhäsion von neisseria-zellen an humane zellen vermitteln
WO2001096381A3 (en) IMMUNIZATION OF DAIRY CATTLE WITH GapC PROTEIN AGAINST STREPTOCOCCUS INFECTION
DE60035485D1 (de) IDENTIFIZIERUNG VON SPEZIFISCHEN DIFFERENZIELL EXPRIMIERTEN ANTIGENEN AUS MYCOBACTERIUM UND MEDIZINISCHE VERWENDUNG DER MYCOBAKTERIUMPROTEINE Rv0068 UND Rv3407
DE69833568D1 (de) Isolierte stämme von staphylococcus aureus und daraus hergestellte impfstoffe
WO2000065063A3 (en) Nucleic acid vaccines against rickettsial diseases and methods of use
ATE353226T1 (de) Adjuvanszusammensetzung enthaltend fha oder ein fha-fragment in freier form
WO2004011496A3 (en) Novel t-cell proteins, peptides and antibodies derived therefrom and uses thereof
EP1334131A4 (en) MONOCLONAL ANTIBODIES AGAINST THE MAP PROTEIN AND METHOD OF USING THE SAME IN THE TREATMENT OR PREVENTION OF INFECTIONS